Neoadjuvant chemoimmunotherapy in patients with locally advanced squamous head and neck cancer: A retrospective study
Neoadjuvant chemoimmunotherapy significantly improves the pathological response rate and R0 resection rate in patients with locally advanced HNSCC with a low incidence of treatment-related adverse events, and our findings suggest its potential as a treatment strategy for locally advanced HNSCC.
Authors
- Lingfeng Xu (ORCID: https://orcid.org/0000-0002-8996-0686)
- Qi‐Fang Huang (ORCID: https://orcid.org/0000-0002-9780-4237)
- Jian Chen (ORCID: https://orcid.org/0000-0002-0438-7631)
- Yuan Wu (ORCID: https://orcid.org/0000-0002-3282-1298)
Institutions
- Hubei Cancer Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-10-14
- DOI
- https://doi.org/10.3389/fonc.2025.1576800
- Citations
- 2
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.70